An international research team reveals new molecular mechanisms associated with pathogenic mutations in the protein ...

On July 2, the U.S. Food and Drug Administration (FDA) approved a new drug for treating Alzheimer’s disease. Donanemab, or Kisunla, is the third drug approved to target one of the causes of ...

Another piece of the dementia puzzle may finally have been found. In A Nutshell Scientists discovered ultrathin tubes (hundreds of nanometers wide) connecting brain cells that transport proteins and ...

Scientists from St Petersburg University and the University of Montpellier have developed the first software enabling the prediction of pairs of proteins in amyloid fibrils capable of co-aggregation, ...

Seeding Plaques:Peter Lansbury and colleagues identified a possible mechanism for the formation of amyloid plaques in Alzheimer's disease. J.T. Jarrett, E.P. Berger, P.T. Lansbury, Jr., "The carboxy ...

A protein notorious for its role in Alzheimer’s disease may hold the key to supercharging the aging immune system, according to new research. Scientists have found that a byproduct of amyloid-beta ...

Illustration showing Alzheimer's disease affecting the hippocampus. Alzheimer's is a neurodegenerative disease that causes the loss of brain tissue. This leads to the progressive and irreversible loss ...

A new study shows that the way amyloid proteins—implicated in Alzheimer's disease—assemble into fibrils can be significantly influenced by the spin orientation of electrons on magnetized surfaces.

Alzheimer's disease starts with a sticky protein called amyloid beta that builds up into plaques in the brain, setting off a chain of events that results in brain atrophy and cognitive decline. The ...

A new study has found that light therapy applied to mice during deep sleep increased the brain’s ability to clear away beta-amyloid, a toxic protein linked to the development of Alzheimer’s disease.